Newlink Genetics(NLNK)

2 %

今开:2.01昨收:1.91
最高:2.1最低:1.91
涨停价:跌停价:
总市值:74625240

Newlink Genetics的热门评论

chuminhua09-18 22:46

$Newlink Genetics(NLNK)$ NewLink 公司9月17日宣布,FDA已经受理默沙东(MSD)埃博拉疫苗V920的新药上市申请(BLA),用于预防埃博拉病感染相关疾病。FDA同时授予V920优先审评资格,预定审批期限是2020/3/14。014年底,当非洲西部埃博拉疫情达到高峰时,默沙东从NewLink公司签署了一项全球独家授权...

东莱千户03-31 15:33

$Newlink Genetics(NLNK)$ Background: NLG207 (formerly CRLX101) is an investigational nanoparticle-drug conjugate (NDC) composed of a cyclodextrin-based polymer backbone linked to camptothecin, a topoisomerase-1 inhibitor. NDCs enhance drug delivery to tumors where gradual pa...

Newlink Genetics的最新评论

chuminhua09-18 22:46

$Newlink Genetics(NLNK)$ NewLink 公司9月17日宣布,FDA已经受理默沙东(MSD)埃博拉疫苗V920的新药上市申请(BLA),用于预防埃博拉病感染相关疾病。FDA同时授予V920优先审评资格,预定审批期限是2020/3/14。014年底,当非洲西部埃博拉疫情达到高峰时,默沙东从NewLink公司签署了一项全球独家授权...查看全文

东莱千户03-31 15:33

$Newlink Genetics(NLNK)$ Background: NLG207 (formerly CRLX101) is an investigational nanoparticle-drug conjugate (NDC) composed of a cyclodextrin-based polymer backbone linked to camptothecin, a topoisomerase-1 inhibitor. NDCs enhance drug delivery to tumors where gradual pa...查看全文

Newlink Genetics的公告

$Newlink Genetics(NLNK)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001126234-19-000086 Size: 27 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$Newlink Genetics(NLNK)$ 8-K - Current report Filed: 2019-07-30 AccNo: 0001126234-19-000084 Size: 185 KBItem 2.02: Results of Operations and Financial ConditionItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compe...

$Newlink Genetics(NLNK)$ 8-K - Current report Filed: 2019-05-23 AccNo: 0001126234-19-000065 Size: 60 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接